CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Comparative study of efficacy and safety of topical cyclosporine 0.1% and tacrolimus ointment 0.1% therapy with fluorometholone 0.1% for vernal keratoconjunctivitis

Author: 
Shalini Gupta, Poonam Gupta and Saurabh Gupta
Subject Area: 
Health Sciences
Abstract: 

Aim: To evaluate and compare the efficacy and safety of eyedrop cyclosporine (CsA) 0.1%, eye ointment tacrolimus (TCA) 0.1% and eyedrop fluorometholone (FML) 0.1% in patients of VKC. Methods: Prospective and Interventional Randomised Comparative Double Blinded Study conducted at Baba Saheb Ambedkar Hospital, New Delhi during August 2017 to December 2018.All 60 patients of 5 to 20 years age with moderate to severe VKC randomly divided into three groups A,B and C of 20 patients each and were treated with cyclosporine 0.1% eyedrops, tacrolimus 0.1% ointment and flurometholone 0.1% eye drops respectively. Patients were followed up after 7,14,30,60 and 90 days. Quantitative variables were compared using ANOVA/Kruskal Wallis Test and paired t test/Wilcoxon. Qualitative variables were correlated using Chi-Square test /Fisher’s exact test. Results: In CsA group symptoms and signs except except foreign body sensation and papillary hypertrophy were decreased earliest at 7 days and these two started improving by 1 month. TCLand FML group showed improvement in all symptoms and signs except papillary hypertrophy after 7 days of treatment. Later started improving by 14 day with FML while it took 60 days with TCA. No changes in fundus and IOP with CsA and TCA was noted whereas, Significant rise in IOP was seen in three patients withFML but no fundus changes. Conclusion: FML has early and maximum effect than others, but considering IOP rise seen with it, TCA and CsA can be safely used as an alternative to topical fluorometholone.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran